Aakaar Medical Technologies IPO Details: Price, Dates & Financials

Shares reserved for the market maker in Aakaar Medical Technologies IPO: Up to ₹1 Cr. The market maker provides two-way quotes after listing to keep the stock liquid.

Pre-issue shareholding: 10,422,416 shares. Post-issue shareholding: 14,172,816 shares.

Aakaar Medical Technologies IPO is a Fresh Capital issue. Issue type: Bookbuilding IPO. Face value is ₹10.

The UPI mandate for Aakaar Medical Technologies IPO needs to be accepted by 24 Jun 2025. Approve the mandate request in your UPI app before the deadline, otherwise your bid may be rejected.

The Red Herring Prospectus (RHP) of Aakaar Medical Technologies IPO is available on the website of the lead manager and the stock exchange (NSE SME) — see the lead manager links on the main page.

The DRHP is the initial offer document filed for regulatory review, while the RHP includes updated disclosures, final issue details, and the price band (when announced). Comparing both documents helps investors identify changes in the Aakaar Medical Technologies IPO's financial information, risks, and offer terms before investing in the Aakaar Medical Technologies IPO. Reviewing both documents provides a clearer understanding of the Aakaar Medical Technologies IPO before making an investment decision.

The DRHP and RHP of the Aakaar Medical Technologies IPO disclose potential risks related to the company's business, financial performance, legal matters, and industry conditions. Reviewing these documents helps investors identify potential concerns about the Aakaar Medical Technologies IPO, evaluate the Aakaar Medical Technologies IPO's risk factors, and make a more informed decision before investing in the Aakaar Medical Technologies IPO.